FIELD: medicine. SUBSTANCE: method involves determining gamma-interferon level in patient blood serum and lacrimal fluid of the ill eye. Its contents being found to be equal to or greater than 200 pcg in blood serum or below 7000 pcg in the lacrimal fluid, worsening of clinical picture of the disease is to be predicted. EFFECT: enhanced accuracy of prognosis; evaluated metastasis risk. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING UVEITIC MELANOMA CLINICAL COURSE | 1999 |
|
RU2149404C1 |
METHOD FOR PREDICTING CLINICAL DEVELOPMENT COURSE OF UVEAL MELANOMA | 1998 |
|
RU2146823C1 |
METHOD OF REVEALING LATENT METASTATIC SPREAD IN PATIENTS WITH UVEAL MELANOMA | 1998 |
|
RU2147373C1 |
METHOD OF TREATING UVEAL MELANOMA | 2000 |
|
RU2175242C1 |
METHOD FOR SETTING DIFFERENTIAL DIAGNOSIS OF LEIOMYOMA AND IRIS MELANOMA | 2001 |
|
RU2199124C1 |
METHOD OF TREATING UVEAL MELANOMA | 2000 |
|
RU2169006C1 |
METHOD FOR PREDICTING CLINICAL FLOW OF UVEAL MELANOMA | 2001 |
|
RU2193200C1 |
METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT | 2001 |
|
RU2197731C2 |
METHOD FOR PREDICTING CLINICAL DEVELOPMENT COURSE OF UVEAL MELANOMA | 2001 |
|
RU2192812C1 |
METHOD FOR DETECTING AN INFLAMMATORY COMPONENT THAT PROMOTES TUMOR GROWTH IN INITIAL CHOROIDAL MELANOMA | 2020 |
|
RU2748528C1 |
Authors
Dates
2000-10-20—Published
1999-08-09—Filed